Spartacus II Launches $200M SPAC IPO, Flags High Dilution Risk

TL;DR

**Avoid Spartacus Acquisition Corp. II (TMTSU) unless you're comfortable with massive dilution and significant conflicts of interest favoring the sponsor over public shareholders.**

AI Summary

Spartacus Acquisition Corp. II (TMTSU) is launching an initial public offering of 20,000,000 units at $10.00 per unit, aiming to raise $200,000,000 for a business combination. Each unit comprises one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The company, a blank check entity, has not yet identified a target business. Its sponsor, Spartacus Sponsor II LLC, acquired 7,666,667 Class B ordinary shares for a nominal $25,000 on November 5, 2025, and will purchase 3,825,000 private placement warrants at $1.00 each. Public shareholders face immediate and substantial dilution due to the sponsor's low-cost founder shares and potential anti-dilution rights, which could result in Class A ordinary shares being issued on a greater than one-to-one basis upon conversion. The company has 24 months from the offering's closing to complete an initial business combination, or it will liquidate, redeeming public shares at their trust account value. Significant conflicts of interest exist, as management and the sponsor stand to profit substantially even if the acquired business underperforms for public shareholders.

Why It Matters

This S-1 filing reveals Spartacus Acquisition Corp. II's intent to raise $200 million, offering investors a chance to participate in a SPAC without a defined target. However, the significant dilution from the sponsor's founder shares, acquired for a mere $25,000, and the potential for additional dilution from warrants and working capital loans, creates a substantial risk for public investors. This structure, common in SPACs, highlights the inherent conflict of interest where the sponsor benefits even if the post-merger company underperforms, potentially impacting investor returns and the broader market's perception of SPAC viability. Competitively, this SPAC enters a crowded market, needing to find an attractive target within 24 months while navigating these internal structural challenges.

Risk Assessment

Risk Level: high — The risk level is high due to the substantial dilution faced by public shareholders, as the sponsor acquired 7,666,667 Class B ordinary shares for only $25,000. This nominal purchase price creates a significant incentive for the sponsor to complete any business combination, even if it's unprofitable for public shareholders, as they stand to make a substantial profit. Additionally, up to $1,500,000 in working capital loans from the sponsor can be converted into warrants at $1.00 each, further increasing potential dilution.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the potential for significant dilution and conflicts of interest before considering an investment in Spartacus Acquisition Corp. II. Given the sponsor's low-cost entry and the potential for substantial profit even if the target underperforms, it would be prudent to wait until a definitive business combination target is identified and its terms are fully disclosed, allowing for a more informed risk-reward assessment.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$0

total Debt

$0

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

$0

revenue Growth

N/A

Key Numbers

• $200,000,000 — Public Offering Price (Amount Spartacus Acquisition Corp. II aims to raise from its IPO.)
• 20,000,000 — Units Offered (Number of units being sold in the initial public offering at $10.00 per unit.)
• $10.00 — Price Per Unit (The offering price for each unit, consisting of one Class A ordinary share and one-third of a warrant.)
• $11.50 — Warrant Exercise Price (The price at which each whole warrant entitles the holder to purchase one Class A ordinary share.)
• 7,666,667 — Class B Ordinary Shares (Number of founder shares purchased by Spartacus Sponsor II LLC for $25,000.)
• $25,000 — Sponsor's Founder Share Cost (The aggregate amount paid by the sponsor for its initial Class B ordinary shares on November 5, 2025.)
• 3,825,000 — Private Placement Warrants (Number of warrants Spartacus Sponsor II LLC committed to purchase at $1.00 per warrant.)
• 24 months — Business Combination Deadline (The period Spartacus Acquisition Corp. II has to complete an initial business combination from the closing of the offering.)
• $300,000 — Sponsor Loan Repayment (Maximum amount of loans from the sponsor to be repaid for offering-related and organizational expenses.)
• $10,000 — Monthly Sponsor Payment (Amount paid monthly to the sponsor for office space, utilities, and administrative support.)

Key Players & Entities

• Spartacus Acquisition Corp. II (company) — Registrant and blank check company
• Igor Volshteyn (person) — Chief Executive Officer of Spartacus Acquisition Corp. II
• Spartacus Sponsor II LLC (company) — Sponsor of Spartacus Acquisition Corp. II
• M. Klein and Company, LLC (company) — Purchased founder shares from the sponsor
• BTIG, LLC (company) — Representative of the underwriters for the IPO
• Continental Stock Transfer & Trust Company (company) — Trustee for the U.S.-based trust account
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• $200,000,000 (dollar_amount) — Total public offering price for 20,000,000 units
• $25,000 (dollar_amount) — Aggregate price paid by sponsor for 7,666,667 Class B ordinary shares
• $1.00 (dollar_amount) — Price per private placement warrant purchased by the sponsor

FAQ

Risk Factors

• Dilution from Sponsor Shares and Warrants [high — financial]: The sponsor acquired 7,666,667 Class B shares for $25,000 and will purchase 3,825,000 private placement warrants at $1.00 each. This structure, combined with potential anti-dilution adjustments, can significantly dilute public shareholders' ownership and earnings per share.
• Dependence on Business Combination Target [high — operational]: As a blank check company, Spartacus Acquisition Corp. II has no identified target business and is entirely dependent on identifying and completing a business combination within 24 months. Failure to do so will result in liquidation and redemption of public shares.
• Limited Operating History and No Revenue [high — financial]: The company is an early-stage entity with no operating history or revenue. Its financial condition and results of operations are solely dependent on the success of its initial public offering and subsequent business combination.
• Redemption Risk [medium — financial]: Public shareholders have the right to redeem their shares if they do not approve of the business combination. If a significant number of redemptions occur, the company may not have sufficient funds to complete the transaction.
• Sponsor Loan Repayment [medium — financial]: The company may repay up to $300,000 in loans from the sponsor for offering-related and organizational expenses. This repayment obligation reduces the capital available for the business combination.
• Ongoing Sponsor Fees [low — financial]: The company will pay the sponsor $10,000 per month for office space, utilities, and administrative support. These ongoing expenses reduce cash available for operations and the business combination.
• Conflicts of Interest [high — legal]: Management and the sponsor have potential conflicts of interest, as they may profit from the business combination and related transactions even if the acquired business underperforms for public shareholders.
• Market Volatility Affecting Business Combination [medium — market]: The success of the business combination is subject to market conditions, including the availability of financing and the valuation of potential target companies, which can be volatile.

Industry Context

Spartacus Acquisition Corp. II operates in the Special Purpose Acquisition Company (SPAC) sector. The SPAC market has seen significant growth and subsequent volatility, with increased regulatory scrutiny. Companies like Spartacus aim to leverage this structure to bring private companies public, often in technology or growth-oriented sectors, but face challenges in identifying suitable targets and completing transactions amidst market fluctuations.

Regulatory Implications

As a SPAC, Spartacus Acquisition Corp. II is subject to SEC regulations governing IPOs and business combinations. The structure itself, particularly the sponsor's economics and potential conflicts of interest, attracts regulatory attention. Changes in accounting standards or disclosure requirements for SPACs could impact reporting and investor perception.

What Investors Should Do

1. Scrutinize the proposed business combination target for fundamental value and management quality, considering the sponsor's incentives.
2. Understand the significant dilution from founder shares and warrants, and model potential EPS impact.
3. Assess the company's ability to complete a business combination within the 24-month timeframe, given market conditions and target availability.
4. Evaluate the sponsor's track record in identifying and executing successful business combinations.
5. Consider the redemption rights and their potential impact on the company's capital structure post-combination.

Key Dates

• 2025-11-05: Sponsor acquired Class B ordinary shares — Established the sponsor's initial equity stake at a nominal cost, highlighting potential for significant returns and dilution for public investors.

Glossary

Blank Check Company

A shell corporation that is set up to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (Spartacus Acquisition Corp. II is a blank check company, meaning it has no current business operations and its sole purpose is to find and merge with another company.)

Unit

A security that combines two or more different types of securities, typically stocks and warrants, offered together as a package. (The IPO units consist of Class A ordinary shares and redeemable warrants, which investors purchase together.)

Redeemable Warrant

A warrant that gives the holder the right to purchase a share of stock at a specified price, but which may also be redeemed by the issuer under certain conditions. (These warrants are exercisable at $11.50 and are part of the IPO units, representing potential future dilution.)

Class B Ordinary Shares

A class of shares typically held by founders or sponsors, often with different voting rights or conversion privileges compared to Class A shares. (The sponsor holds these shares, which are convertible into Class A shares and are subject to anti-dilution provisions.)

Private Placement Warrants

Warrants sold directly to a select group of investors, often sponsors or institutional investors, outside of a public offering. (The sponsor is purchasing these warrants, which adds to the potential dilution for public shareholders.)

Business Combination

The merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business transaction with one or more target businesses. (This is the primary objective of Spartacus Acquisition Corp. II; failure to complete one within 24 months leads to liquidation.)

Trust Account

A segregated account where funds raised from an IPO are held until a business combination is completed or the company liquidates. (Public shareholders' investment is held here, and they will receive the pro-rata value from this account upon liquidation.)

Anti-Dilution Protection

Provisions in a security's terms that protect investors from a decrease in the value of their investment due to the issuance of new shares at a lower price. (These provisions on the sponsor's Class B shares could lead to the issuance of more shares than initially anticipated, increasing dilution.)

Year-Over-Year Comparison

As this is an S-1 filing for an initial public offering, there is no prior filing to compare against. Key metrics such as revenue, net income, and operating margins are not applicable at this pre-IPO stage. The primary focus is on the offering structure, the capital to be raised ($200,000,000), the dilution inherent in the sponsor's stake (7,666,667 Class B shares for $25,000), and the timeline for a business combination (24 months).

Key Financial Figures

• $200,000,000 — O COMPLETION, DATED DECEMBER 23, 2025 $200,000,000 Spartacus Acquisition Corp. II 20,0
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $300,000 — irements, subject to an annual limit of $300,000 of the interest earned on the funds hel
• $1.00 — hare at $11.50 per share, at a price of $1.00 per warrant, in a private placement tha
• $10,000 — s, and we will begin paying our sponsor $10,000 per month for office space, utilities a
• $1,500,000 — our initial business combination, up to $1,500,000 of such loans may be convertible into w
• $100,000 — (net of permitted withdrawals and up to $100,000 of interest income to pay dissolution e
• $0.10 — 196,000,000 ____________ (1) Includes $0.10 per unit or $2,000,000 in the aggregate
• $2,000,000 — _______ (1) Includes $0.10 per unit or $2,000,000 in the aggregate (or up to $2,300,000 i
• $2,300,000 — r $2,000,000 in the aggregate (or up to $2,300,000 if the underwriters' option to purchase
• $200 m — warrants described in this prospectus, $200 million, or $230 million if the underwrit
• $230 million — ed in this prospectus, $200 million, or $230 million if the underwriters' overallotment opti

Filing Documents

• ea0270643-01.htm (S-1) — 4116KB
• ea027064301ex4-1_spartacus2.htm (EX-4.1) — 34KB
• ea027064301ex4-2_spartacus2.htm (EX-4.2) — 35KB
• ea027064301ex4-3_spartacus2.htm (EX-4.3) — 37KB
• ea027064301ex4-4_spartacus2.htm (EX-4.4) — 212KB
• ea027064301ex10-1_spartacus2.htm (EX-10.1) — 64KB
• ea027064301ex10-2_spartacus2.htm (EX-10.2) — 92KB
• ea027064301ex10-3_spartacus2.htm (EX-10.3) — 127KB
• ea027064301ex10-4_spartacus2.htm (EX-10.4) — 59KB
• ea027064301ex10-5_spartacus2.htm (EX-10.5) — 130KB
• ea027064301ex10-6_spartacus2.htm (EX-10.6) — 26KB
• ea027064301ex10-7_spartacus2.htm (EX-10.7) — 66KB
• ea027064301ex10-8_spartacus2.htm (EX-10.8) — 24KB
• ea027064301ex14-1_spartacus2.htm (EX-14.1) — 79KB
• ea027064301ex23-1_spartacus2.htm (EX-23.1) — 2KB
• ea027064301ex99-1_spartacus2.htm (EX-99.1) — 61KB
• ea027064301ex99-2_spartacus2.htm (EX-99.2) — 46KB
• ea027064301ex99-3_spartacus2.htm (EX-99.3) — 3KB
• ea027064301ex99-4_spartacus2.htm (EX-99.4) — 4KB
• ea027064301ex99-5_spartacus2.htm (EX-99.5) — 4KB
• ea027064301ex-fee_spartacus2.htm (EX-FILING FEES) — 22KB
• 0001213900-25-125410.txt ( ) — 8503KB
• ck0002097364-20251223.xsd (EX-101.SCH) — 8KB
• ck0002097364-20251223_def.xml (EX-101.DEF) — 13KB
• ck0002097364-20251223_lab.xml (EX-101.LAB) — 111KB
• ck0002097364-20251223_pre.xml (EX-101.PRE) — 60KB
• ea0270643-01_htm.xml (XML) — 986KB
• ea027064301ex-fee_spartacus2_htm.xml (XML) — 10KB

Risk Factors

Risk Factors 48 Cautionary Note Regarding Forward-Looking Statements 96

Use of Proceeds

Use of Proceeds 97 Dividend Policy 100

Dilution

Dilution 101 Capitalization 104

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 105 Proposed Business 111 Effecting our Initial Business Combination 128 Management 148 Principal Shareholders 159 Certain Relationships and Related Party Transactions 162

Description of Securities

Description of Securities 165 Taxation 186

Underwriting

Underwriting 197 Legal Matters 207 Experts 207 Where You Can Find Additional Information 207 Index to Financial Statements F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the or symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under "Risk Factors" and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: "amended and restated memorandum and articles of association" are to our amended and restated memorandum and articles of association to be in effect

View Full Filing

View this S-1 filing on SEC EDGAR